- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 16/10 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
Patent holdings for IPC class C07K 16/10
Total number of patents in this class: 5300
10-year publication summary
|
245
|
225
|
256
|
266
|
279
|
422
|
529
|
511
|
463
|
263
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2895 |
147 |
| Humabs Biomed SA | 124 |
85 |
| Regeneron Pharmaceuticals, Inc. | 4407 |
82 |
| Vanderbilt University | 1928 |
80 |
| The Rockefeller University | 575 |
76 |
| The Scripps Research Institute | 1357 |
76 |
| Duke University | 3103 |
64 |
| VIR Biotechnology, Inc. | 148 |
59 |
| California Institute of Technology | 3990 |
49 |
| The Wistar Institute of Anatomy and Biology | 462 |
47 |
| Dana-Farber Cancer Institute, Inc. | 2615 |
40 |
| The Trustees of Columbia University in the City of New York | 3595 |
38 |
| The Trustees of the University of Pennsylvania | 4376 |
37 |
| Academia Sinica | 946 |
37 |
| Institut Pasteur | 784 |
37 |
| International AIDS Vaccine Initiative | 90 |
35 |
| Visterra, Inc. | 132 |
35 |
| The Regents of the University of California | 20230 |
30 |
| Genmab A/S | 438 |
30 |
| MedImmune Limited | 625 |
29 |
| Other owners | 4187 |